4D Molecular Therapeutics (FDMT) Shares Outstanding (Entity) (2019 - 2026)
4D Molecular Therapeutics (FDMT) posted Shares Outstanding (Entity) of 70.27 million for Q2 2026, up 50.5% from 46.7 million a year earlier and up 3.2% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025, 4D Molecular Therapeutics' Shares Outstanding (Entity) came in at 57.61 million, up 25.8% from FY2024.
- Annual Shares Outstanding (Entity) has increased for six consecutive years, with a five-year compound annual growth rate of 55.0% (FY2020 to FY2025).
- In prior years, 4D Molecular Therapeutics' Shares Outstanding (Entity) was 45.79 million in FY2024 (+6.3%), 43.08 million in FY2023 (+32.0%), 32.63 million in FY2022 (+1.2%) and 32.22 million in FY2021 (+401.1%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2019.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last three quarters, with growth averaging 15.2% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q3 2021, with growth of 416.7%; the weakest was Q3 2025, with a decline of 10.0%.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 68.06 million (Q1 2026), 57.61 million (Q4 2025) and 46.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | 4D Molecular Therapeutics | 891.75 Mn | -568.19 Mn | - | 70.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.27 Mn |
| Mar 31, 2026 | 68.06 Mn |
| Dec 31, 2025 | 57.61 Mn |
| Sep 30, 2025 | 46.77 Mn |
| Jun 30, 2025 | 46.70 Mn |
| Mar 31, 2025 | 46.32 Mn |
| Dec 31, 2024 | 45.79 Mn |
| Sep 30, 2024 | 52.00 Mn |
| Jun 30, 2024 | 51.91 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Dec 31, 2023 | 43.08 Mn |
| Sep 30, 2023 | 42.75 Mn |
| Jun 30, 2023 | 42.02 Mn |
| Mar 31, 2023 | 33.24 Mn |
| Dec 31, 2022 | 32.63 Mn |
| Sep 30, 2022 | 32.39 Mn |
| Jun 30, 2022 | 32.38 Mn |
| Mar 31, 2022 | 32.26 Mn |
| Dec 31, 2021 | 32.22 Mn |
| Sep 30, 2021 | 27.17 Mn |
API Access
4D Molecular Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();